1.93
前日終値:
$1.84
開ける:
$1.82
24時間の取引高:
1.19M
Relative Volume:
0.73
時価総額:
$294.00M
収益:
$137.74M
当期純損益:
$-27.97M
株価収益率:
-12.06
EPS:
-0.16
ネットキャッシュフロー:
$-9.61M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-18.91%
6か月 パフォーマンス:
+6.63%
1年 パフォーマンス:
-26.89%
Heron Therapeutics Inc Stock (HRTX) Company Profile
名前
Heron Therapeutics Inc
セクター
電話
(858) 251-4400
住所
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HRTX
Heron Therapeutics Inc
|
1.93 | 294.00M | 137.74M | -27.97M | -9.61M | -0.16 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
2024-04-23 | 開始されました | CapitalOne | Overweight |
2024-03-13 | 繰り返されました | Needham | Buy |
2020-05-27 | 開始されました | Guggenheim | Buy |
2020-02-20 | 繰り返されました | Needham | Buy |
2019-01-16 | 繰り返されました | Needham | Buy |
2018-04-05 | 開始されました | Evercore ISI | Outperform |
2018-03-19 | 繰り返されました | Mizuho | Buy |
2018-03-01 | 繰り返されました | Needham | Buy |
2018-01-03 | 開始されました | Leerink Partners | Outperform |
2017-09-27 | 開始されました | Northland Capital | Outperform |
2017-02-27 | 開始されました | Needham | Buy |
2016-10-26 | 開始されました | Aegis Capital | Buy |
2016-09-06 | 再開されました | Lake Street | Buy |
2016-05-03 | 開始されました | Cantor Fitzgerald | Buy |
2015-12-10 | 開始されました | Lake Street | Buy |
2015-09-23 | 繰り返されました | Leerink Partners | Outperform |
2015-09-02 | 開始されました | BofA/Merrill | Buy |
2015-08-03 | 繰り返されました | Brean Capital | Buy |
2015-06-30 | 繰り返されました | JMP Securities | Mkt Outperform |
2015-06-19 | 繰り返されました | Leerink Partners | Outperform |
2014-08-07 | 開始されました | Noble Financial | Buy |
すべてを表示
Heron Therapeutics Inc (HRTX) 最新ニュース
Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop - simplywall.st
Quinn Opportunity Partners LLC Acquires New Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Takes $208,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Raymond James Financial Inc. Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Exploring High Growth Tech Stocks In The US Market April 2025 - Yahoo
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term - Yahoo
Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5? - Insider Monkey
Reviewing Heron Therapeutics (NASDAQ:HRTX) and ULURU (OTCMKTS:ULUR) - Defense World
Richmond Brothers Inc. Raises Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Tejara Capital Ltd Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
10 Hot Biotech Stocks Under $5 - Insider Monkey
Monaco Asset Management SAM Sells 465,674 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics to Report Fourth Quarter and Full Year 2024 F - GuruFocus.com
Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat
CM Management LLC Acquires 200,000 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Why Heron Therapeutics Inc Stock Might Make Sense If Bought Today - Stocks Register
Los Angeles Capital Management LLC Sells 153,181 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesday - Defense World
Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) - Seeking Alpha
Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World
Heron Therapeutics (HRTX) to Release Earnings on Tuesday - MarketBeat
What is Northland Capmk's Estimate for HRTX Q1 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Position Decreased by Los Angeles Capital Management LLC - The AM Reporter
Heron Therapeutics (NASDAQ:HRTX) Raised to "Buy" at StockNews.com - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO. - MarketBeat
Heron Therapeutics Inc (HRTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):